
In China, For Global
Provide patients with world-class, trustworthy, affordable, and innovative drugs.
Company at a Glance
Original Innovation, Science Oriented
An innovative and globally competitive biopharmaceutical company with a whole-industry-chain layout.
- Priority programs in development
- 30+
- Fermentation capacity at Wujiang and Lingang Phase I
- 46,500 L
- Countries and regions where toripalimab is approved
- 50+


